Enrolling by Invitation
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.
NCT06762431
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukaemia (CLL), Disease Attributes, +15 more
- Locations
-
- Hematology/Oncology department Vitebsk, Select A State, Belarus